Dialysis Provider DaVita receives Freedom Award from DOD
DENVER–(BUSINESS WIRE)–DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, learned today that it has received the prestigious Secretary of...
View ArticleHemodialysis: Shorter Sessions and Higher Mortality, Hospitalizations
Study: Shorter Hemodialysis Session Length Is Strongly Associated With Higher Rates of Mortality and Hospitalization Steven Brunelli, MD, MSCE, senior director, DaVita Clinical Research...
View ArticleDialysis: Targeted Medication Therapy Management Improves Outcomes for...
Study: Targeted Medication Therapy Management (MTM) Improves Outcomes for Dialysis Patients and the Health Care System Author: Josh Howland, Pharm.D., MBA, DaVita Rx manager – Targeted Medication...
View ArticleDialysis Patient Shares Experience with Kidney Disease Research
Hemodialysis.com Interview with dialysis patient Harvey regarding her experience with the DaVita Clinical Research program. In conjunction with DaVita’s “Inspired to Give,” series, Marie Benz, MD of...
View ArticleDialysis Patients: Benefits of Maintaining Employment
Benefits for Dialysis Patients Who Work Highlighted by DaVita The United States Renal Data System (USRDS) shows that 50 percent of all dialysis patients are of working age, yet only one in five of...
View ArticleDaVita Clinical Research: Interview with Amy Young, Vice President and...
Amy Young, Vice President and General Manager DaVita Clinical Research Background: Amy Young has been a vital part of DCR bringing deep experience in the execution of research required to bring new...
View ArticleDaVita Prepares Dialysis Patients for Winter Storm Effects
Recognizing that Winter Storm Pax is blanketing the South with another round of hazardous wintry weather, dialysis provider DaVita has made extensive preparations to minimize the impact to patients of...
View Article